About us

We bring more than hope

We are Pancreatic Cancer UK. We go above and beyond for everyone affected by this disease. Right now, half of people with pancreatic cancer die within three months of diagnosis. Families are left with only hope to hold onto. They need more. So, we do more.

We bring more breakthroughs through research, more change through campaigning, and more support through our expert nurses. We make more noise because people have gone unheard. We are relentless because the disease is ruthless. We care more because people feel forgotten.

Because people with pancreatic cancer need more than hope.

Campaigners

Our vision and mission

We won’t stop until we achieve our vision – for everyone with pancreatic cancer to live long and well. Read our five-year strategy. 

Read more
runner with two PCUK workers

Our people

Our people make all of this possible – an incredible community of staff, volunteers and supporters. Amazing people, just like you.

Read more

Our vacancies

We’re committed to supporting people with pancreatic cancer right now, and funding research and campaigning to transform the future.  

Read more
lewis

What we do

We bring more change through campaigning, more breakthroughs through research and more support through expert nurses.

Find out what we do
  • Support with the rising cost of living

    Support with the rising cost of living

    Find out how to get the support you need to deal with the rising cost of living, from benefits and grants to tips for eating well on a budget.

  • Four esteemed new trustees bolster our board

    Four esteemed new trustees bolster our board

    We are delighted to announce that four new trustees have joined our Board of Trustees.

  • Glasgow scientists to uncover how ‘time bomb’ cysts develop into deadliest common cancer

    Glasgow scientists to uncover how ‘time bomb’ cysts develop into deadliest common cancer

    We have awarded almost £500,000 to researchers at the University of Glasgow to uncover why pancreatic cysts develop into pancreatic cancer.